Date Presented 4/18/2015

Through our novel prospective cohort study guided by the International Classification of Functioning, Disability and Health (ICF) framework, we identified and validated a battery of outcome measures in congenital muscular dystrophy (CMD). We discuss our 3-yr study, and we provide insight into disease progression as well as measures best suited for clinical trials.

You do not currently have access to this content.